BRC Investment Management’s Edwards Lifesciences EW Stock Holding History

BRC Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$754K	Buy	+18,771	New	+$707K	0.13%	135

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BRC Investment Management's EW Position: Q3 2016 in Review

BRC Investment Management opened a new position in Edwards Lifesciences (EW) in Q3 2016: 18,771 shares worth $754K. The stake represents 0.13% of the portfolio and ranks #135 among its holdings.

693 funds tracked by Wall St. Rank hold EW as of Q3 2016.

BRC Investment Management held 18,771 shares of Edwards Lifesciences worth $754K as of Q3 2016.
Edwards Lifesciences was a new BRC Investment Management position in Q3 2016.
Edwards Lifesciences made up 0.13% of BRC Investment Management's portfolio in Q3 2016, its #135 holding.
693 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2016.

Based on BRC Investment Management's 13F filing for Q3 2016, filed 31 Oct 2016.